June 2010
- June 28, 2010
RADIENT PHARMA Investor Call on 6/24/2010 
- June 24, 2010
RADIENT PHARMA Strategic Partner Jaiva Technologies Plans to Submit Application For Phase II Human Clinical Trials For Non-Small Cell Lung Carcinoma; Advancing Commercialization of RPC’s CIT™ Cancer Vaccine In India 
- June 22, 2010
RADIENT PHARMA Schedules Investor Call To Discuss Onko-Sure™ Commercialization Developments
- June 15, 2010
RADIENT PHARMA Announces Latest Developments In Its Onko-Sure™ Commercialization Plan For India; Company’s India-Based Partner Driving Government Backed General Cancer Screening Program
- June 7, 2010
RADIENT PHARMA Announces New Interactive Website Dedicated to Company’s Onko-Sure™ In Vitro Diagnostic Cancer Test
- June 7, 2010
RADIENT PHARMA Provista Life Sciences Initiates Validation Study For Radient Pharmaceuticals’ Onko-Sure™ IVD Cancer Test As a General Cancer Screen
- June 2, 2010
RADIENT PHARMA and Perceptive Imagineering Announce Partnership To Accelerate Commercialization of Onko-Sure™ In Vitro Diagnostic Cancer Test
May 2010
- May 25, 2010
RADIENT PHARMA ANNOuNCES First Quarter 2010 Financial Results; Provides Update On Onko-Sure™ Product Sales And Monetization of Its China-Based Subsidiary Jade Pharmaceuticals
- May 14, 2010
RADIENT PHARMA Accelerating Distributor Partnerships For Its Onko-Sure™ In Vitro Diagnostic Cancer Test in India Via Government And Distributor Meetings
- May 10, 2010
RADIENT PHARMA Announces Dr. Afsaneh Motamed-Khorasani Joins RPC As Director Of Oncology
- May 5, 2010
RADIENT PHARMA Announces Collaboration Agreement With Provista Life Sciences; Provista Providing CLIA Laboratory Services For RPC’s Onko-Sure™ Cancer Test
- May 4, 2010
Provista Life Sciences Validates Radient Pharmaceuticals’ Onko-Sure™ Cancer Test As Breast Cancer Screen
April 2010
- April 29, 2010
RADIENT PHARMA Completes Fourth And Final Closing Of Convertible Promissory Note Financing
- April 26, 2010
RADIENT PHARMA Creates Medical Advisory Board ; Adds Director Of Oncology To Lead Efficacy Efforts For Company’s Onko-Sure™ IVD Cancer Test
- April 22, 2010
RADIENT PHARMA Expands Onko-Sure Commercialization To Include Clia Lab-Based Testing Services
- April 21, 2010
RADIENT PHARMA To Present Onko-Sure™ Cancer Test At Prestigious Annual Oncology Conference
- April 16, 2010
RADIENT PHARMA Reports Third Closing Of Convertible Note Offering, 2009 Year End Results And Fiscal Year 2010 Targets
- April 14, 2010
Advantages of Radient Pharmaceuticals’ Onko-Sure In Vitro Diagnostic Cancer Test Over CEA Published In Journal Of Immunoassay And Immunochemistry
- April 13, 2010
RADIENT PHARMA Completes Second Closing Of Convertible Promissory Note Financing
- April 12, 2010
RADIENT PHARMA Monetizing China-Based JADE Pharmaceutical Division
- April 9, 2010
RADIENT PHARMA Expands Distribution Partnership With Genway Biotech; Company To Commercialize RPC’s Onko-Sure Cancer Test In Russia And Former Soviet Republics
- April 8, 2010
RADIENT PHARMA Extends Onko-Sure Cancer Test Distribution Partnership For The Market Of India That Includes Use As A General Cancer Screen
- April 7, 2010
RADIENT PHARMA Enters Into Collaboration Agreement With Jaiva Technologies To Advance Commercialization Of Radient’s CIT™ Cancer Vaccine In India
March 2010
- March 26, 2010
RADIENT PHARMA NYSE AMEX Grants Extension To Regain Compliance With Continued Listing Standards; Notification Of Late Filing Of Form 10-K
RADIENT PHARMA Completes Convertible Promissory Note Financing
- March 23, 2010
RADIENT PHARMA Publishes White Paper Highlighting Economic & Healthcare Benefits of Government Supported Cancer Screening
RADIENT PHARMA National & Regional Screening Programs (Whitepaper)
January 2010
- January 26, 2010
RADIENT PHARMA Submits Business Plan For Continued NYSE AMEX Listing
|
